GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Mercury Computer Systems (MRCY) SVP, CFO and Treasurer Robert Hult sells 4,469 Shares

August 20, 2010 | About:
insider

insider

57 followers
SVP, CFO and Treasurer of Mercury Computer Systems (MRCY) Robert Hult sells 4,469 shares of MRCY on 08/18/2010 at an average price of $11.01 a share.

Mercury Computer Systems has a market cap of $255.2 million; its shares were traded at around $10.78 with a P/E ratio of 12.4 and P/S ratio of 1.3.

MRCY is in the portfolios of George Soros of Soros Fund Management LLC, Chuck Royce of Royce& Associates, Jim Simons of Renaissance Technologies LLC, James Barrow of Barrow, Hanley, Mewhinney & Strauss.

CFO Recent Trades:



  • Sell: SVP, CFO and Treasurer Robert Hult sold 1,050 shares of MRCY stock on 06/08/2010 at the average price of 10.33. Robert Hult owns at least 66,847 shares after this. The price of the stock has increased by 4.36% since.



This is the insider trade history vs. stock price of MRCY. For the complete insider trading history of MRCY, click here.




Directors and Officers Recent Trades:



  • Sell: SVP and GM, ACS Didier M C Thibaud sold 2,552 shares of MRCY stock on 06/08/2010 at the average price of 10.33. Didier M C Thibaud owns at least 117,776 shares after this. The price of the stock has increased by 4.36% since.
  • Sell: SVP, Human Resources Craig A Saline sold 964 shares of MRCY stock on 06/08/2010 at the average price of 10.33. Craig A Saline owns at least 33,607 shares after this. The price of the stock has increased by 4.36% since.


About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 3.8/5 (4 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK